Phase 2 Chemotherapy Induced Peripheral Neuropathy Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)
Chemotherapy Induced Peripheral NeuropathyDrug-Induced Nephropathy
VM Therapeutics LLC16 enrolled1 locationNCT07072468
Recruiting
Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Malignant Solid NeoplasmChemotherapy Induced Peripheral NeuropathyHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center380 enrolled2 locationsNCT04560673
Recruiting
Phase 2
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Breast CarcinomaChemotherapy Induced Peripheral NeuropathyColon Carcinoma
City of Hope Medical Center120 enrolled2 locationsNCT06731894
Recruiting
Phase 2Phase 3
Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ)
Chemotherapy Induced Peripheral NeuropathyPain SyndromePain, Neuropathic
Bernardino Clavo, MD, PhD42 enrolled2 locationsNCT04299893
Recruiting
Phase 2Phase 3
Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy
Chemotherapy Induced Peripheral Neuropathy
University of British Columbia50 enrolled4 locationsNCT05786599
Recruiting
Phase 2
Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy
PainChemotherapy Induced Peripheral NeuropathySolid Tumor
Yan Yang, MD, Ph.D100 enrolled1 locationNCT04970121
Recruiting
Phase 1Phase 2
EGCG for the Prevention and Treatment of TIPN
Chemotherapy Induced Peripheral Neuropathy
Han Xi Zhao36 enrolled1 locationNCT06524609